RxDoctor Payments Data

William Stefani, MD

Plastic Surgery · Troy, MINPI 1447266945

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.9%), other and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Axogen at 29.0% of the total. 2025 is the largest year on record at $3,316, 4.7 times the $702 reported in 2019.

$5,324in general payments, 2019–2025

Across 76 payments — averaging $70.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$2K
  • Integra Lifesciences Corporation$1K
  • Mentor Worldwide LLC$608
  • AbbVie$586
  • Revance Therapeutics, Inc.$271
  • Merz North America, Inc.$209
  • plus $823 from 15 others
$34,955in research payments, 2019–2025

Across 18 payments — averaging $1941.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$24K
  • Medical Device Business Services, Inc.$11K

What the payments were for

  • Travel & lodging$93718%
  • Food & beverage$2,97456%
  • Gifts$2254%
  • Other$1,18922%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,324 in reported general payments places this provider in the 75th percentile of 155 plastic surgery providers in Michigan.

See all plastic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$33,268
Medicare patients
38
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin21$81
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$52

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Troy

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →